keyword
https://read.qxmd.com/read/38683584/layered-double-hydroxide-based-pdcu-x-ldh-alloy-nanozyme-for-a-singlet-oxygen-boosted-sonodynamic-therapy
#1
JOURNAL ARTICLE
Minli Mo, Yashuo Jiang, Aichun Kang, Kai Song, Hongbin Qi, Jing Li, Shanyue Guan, Shuyun Zhou
Redox nanozymes have demonstrated tremendous promise in disrupting cellular homeostasis toward cancer therapy, but a dysfunctional competition of diverse activities makes it normally restricted by the complex tumor microenvironment (TME). As palladium nanocrystals can achieve the precise regulation of the enzyme-like activity by regulating exposed crystal planes, noble metal nanoalloys can enhance the enzyme-like activity by promoting electron transfer and enhanced active sites. Herein, bimetallic nanoalloys with optimized enzymatic activity were intelligently designed via the interaction between the Pd and layered double hydroxide, denoted as PdCu x @LDH...
April 29, 2024: ACS Applied Materials & Interfaces
https://read.qxmd.com/read/38682188/the-chemokine-cxcl7-is-correlated-with-ldh-a-and-predicts-the-prognosis-of-patients-with-colorectal-cancer
#2
JOURNAL ARTICLE
Hai Liang, Longhai Li, Baoyu Huang, Gang Cheng, Jiafu Ao, Shuli Hao
OBJECTIVE: The aims of this study were to evaluate the correlation between chemokine (C-X-C) ligand 7 (CXCL7) expression and glycolysis and to explore the prognostic significance of CXCL7 in colorectal cancer (CRC). METHODS: The expression of CXCL7 and lactate dehydrogenase A (LDH-A) was measured by immunohistochemistry in tissue from 158 CRC patients. Patients were divided into high expression and low expression groups based on receiver operating characteristic curves and a cut-off value...
April 26, 2024: Frontiers in Bioscience (Landmark Edition)
https://read.qxmd.com/read/38682008/clinicopathological-and-oncological-outcomes-in-upper-extremity-ewing-s-sarcoma-a-single-institutional-experience
#3
JOURNAL ARTICLE
Shivang Shukla, Abhijeet Ashok Salunke, Maharshi Trivedi, Keval Patel, Shivam Pandya, Ritesh Suthar, Tarun Reddy, Kanika Kapoor, Poojitha Yala, Geetha Krishna, Nandlal Bharwani, Shashank Pandya
BACKGROUND: Ewing's sarcoma is highly aggressive bone tumor having predilection for younger age groups with t (11,22) translocation, recombines the FLI-1 and EWS genes on chromosome 22. This disease requires multi-disciplinary treatment withneo-adjuvant chemotherapy followed by surgery or radiotherapy and adjuvant chemotherapy. This study was aimed to assess the demographic distribution, clinical behaviour and oncological outcome of Ewings Sarcoma involving upper extremity. METHODS: From 2015 to 2022, 45 patients of upper extremity Ewing's sarcoma underwent treatment at a territory cancer centre...
March 2024: Journal of Orthopaedics
https://read.qxmd.com/read/38679154/photodynamic-therapy-inhibits-cancer-progression-and-induces-ferroptosis-and-apoptosis-by-targeting-p53-gpx4-slc7a11-signaling-pathways-in-cholangiocarcinoma
#4
JOURNAL ARTICLE
Xiaodong Yan, Zhongmin Li, Huaiyu Chen, Fu Yang, Qing Tian, Yamin Zhang
BACKGROUND: Cholangiocarcinoma (CCA) is a malignant tumor with a poor prognosis. The specific mechanism of photodynamic therapy (PDT) in treating CCA remains unclear. This study aims to investigate the mechanisms of PDT in the treatment of CCA and try to improve the therapeutic effect of PDT by intervening associated signaling pathways. METHODS: The Cell Counting Kit-8 (CCK-8) was used to examine the cytotoxicity of CCA cell lines following PDT. Apoptosis and reactive oxygen species (ROS) levels were measured by flow cytometry...
April 26, 2024: Photodiagnosis and Photodynamic Therapy
https://read.qxmd.com/read/38679017/the-hammersmith-score-optimises-patient-selection-and-predicts-for-overall-survival-in-early-phase-cancer-trial-participants-independent-of-tumour-burden
#5
James Alexander Korolewicz, Bernhard Scheiner, Claudia A M Fulgenzi, Antonio D'Alessio, Alessio Cortellini, Chynna Pascual, Aman Mehan, Sarah Partridge, Dorothy M Gujral, Waleed Mohammed, Oreoluwa Mohammed, Aneta Grzesiak, Lauren Booker, Susan Cleator, Tzveta Pokrovska, Waqar Saleem, James Rackie, Yasmine Needham, Jonathan Krell, Iain McNeish, Laura Tookman, Won-Ho Edward Park, Muzamil Asif, Joanne S Evans, David J Pinato
INTRODUCTION: As tumour response rates are increasingly demonstrated in early-phase cancer trials (EPCT), optimal patient selection and accurate prognostication is paramount. Hammersmith Score (HS), a simple prognostic index derived on routine biochemical measures (Albumin <35g/L, Lactate Dehydrogenase (LDH) >450 IU/L, Sodium <135mmol/L) is a validated predictor of response and survival in EPCT participants. HS has not been validated in the cancer immunotherapy era...
April 27, 2024: Chemotherapy
https://read.qxmd.com/read/38677038/nano-inducer-of-ferroptosis-for-targeted-chemotherapy-of-human-triple-negative-breast-carcinoma
#6
JOURNAL ARTICLE
Neena G Shetake, Sourav Kumar Das, Amit Kumar, Badri N Pandey
Triple negative breast carcinoma (TNBC) accounts for 15-20 % of all incident breast cancers (BC) and is known to be highly invasive, has fewer treatment options, and tends to have a worse prognosis. However, due to its biological heterogeneity and diverse clinical and epidemiological behaviors, TNBC lacks a tumor-specific targeted therapy. In the present work we have developed a TNBC-specific targeted nano-delivery agent comprising of a cRGD labeled magneto-liposome (T-LMD) co-encapsulated with oleic acid coated iron oxide nanoparticles (MN-OA) and doxorubicin (Dox) in the liposome bilayer and core, respectively...
April 20, 2024: Biomater Adv
https://read.qxmd.com/read/38672567/the-sgca-vericiguat-exhibit-cardioprotective-and-anti-sarcopenic-effects-through-nlrp-3-pathways-potential-benefits-for-anthracycline-treated-cancer-patients
#7
JOURNAL ARTICLE
Vincenzo Quagliariello, Massimiliano Berretta, Irma Bisceglia, Ilaria Giacobbe, Martina Iovine, Vienna Giordano, Raffaele Arianna, Matteo Barbato, Francesca Izzo, Carlo Maurea, Maria Laura Canale, Andrea Paccone, Alessandro Inno, Marino Scherillo, Domenico Gabrielli, Nicola Maurea
Anthracycline-induced cardiomyopathies and sarcopenia are frequently seen in cancer patients, affecting their overall survival and quality of life; therefore, new cardioprotective and anti-sarcopenic strategies are needed. Vericiguat is a new oral guanylate cyclase activator that reduces heart failure hospitalizations or cardiovascular death. This study highlighted the potential cardioprotective and anti-sarcopenic properties of vericiguat during anthracycline therapy. Human cardiomyocytes and primary skeletal muscle cells were exposed to doxorubicin (DOXO) with or without a pre-treatment with vericiguat...
April 12, 2024: Cancers
https://read.qxmd.com/read/38672547/development-and-validation-of-an-inflammatory-prognostic-index-to-predict-outcomes-in-advanced-metastatic-urothelial-cancer-patients-receiving-immune-checkpoint-inhibitors
#8
JOURNAL ARTICLE
Sara Mokbel, Giuilia Baciarello, Pernelle Lavaud, Aurelius Omlin, Fabio Calabrò, Richard Cathomas, Stefanie Aeppli, Pauline Parent, Patrizia Giannatempo, Kira-Lee Koster, Naara Appel, Philippe Gonnet, Gesuino Angius, Petros Tsantoulis, Hendrick-Tobias Arkenau, Carlo Cattrini, Carlo Messina, Jean Zeghondy, Cristina Morelli, Yohann Loriot, Vincenzo Formica, Anna Patrikidou
BACKGROUND: Immune checkpoint inhibitors (ICIs) improve overall survival (OS) in advanced/metastatic urothelial cancer (a/mUC) patients. Preliminary evidence suggests a prognostic role of inflammatory biomarkers in this setting. We aimed to develop a disease-specific prognostic inflammatory index for a/mUC patients on ICIs. METHODS: Fifteen variables were retrospectively correlated with OS and progression-free survival (PFS) in a development (D, n = 264) and a validation (V, n = 132) cohort of platinum-pretreated a/mUC pts receiving ICIs at L2 or further line...
April 11, 2024: Cancers
https://read.qxmd.com/read/38672542/predictors-of-survival-treatment-modalities-and-clinical-outcomes-of-diffuse-large-b-cell-lymphoma-in-patients-older-than-70-years-still-an-unmet-medical-need-in-2024-based-on-real-world-evidence
#9
JOURNAL ARTICLE
Luís Alberto de Pádua Covas Lage, Rita Novello De Vita, Lucas Bassolli de Oliveira Alves, Mayara D'Auria Jacomassi, Hebert Fabrício Culler, Cadiele Oliana Reichert, Fábio Alessandro de Freitas, Vanderson Rocha, Sheila Aparecida Coelho Siqueira, Renata de Oliveira Costa, Juliana Pereira
BACKGROUND: Diffuse large B-cell lymphoma (DLBCL) especially affects the older population. Old (≥60 years) and very old age (≥80 years) DLBCL patients often present high-risk molecular alterations, lower tolerability to conventional immunochemotherapy, and poor clinical outcomes. In this scenario, attenuated therapeutic strategies, such as the R-MiniCHOP and R-MiniCHOP of the elderly regimens, have emerged for this particularly fragile population. However, the responses, clinical outcomes, and toxicities of these regimens currently remain poorly understood, mainly because these individuals are not usually included in controlled clinical trials...
April 11, 2024: Cancers
https://read.qxmd.com/read/38665466/evaluation-of-serum-and-salivary-lactate-dehydrogenase-levels-in-patients-with-oral-potentially-malignant-conditions-lesions-a-clinical-and-biochemical-study
#10
JOURNAL ARTICLE
Kumuda Rao, Subhas G Babu, Shishir Ram Shetty, Renita Lorina Castelino
BACKGROUND: Oral cancer encompasses all malignancies that originate in the oral tissues and remains a major public health problem throughout the world as an important case of poor health and illness. Head and neck cancer accounts for 9.8% of the estimated 6,44,600 incidental cancer cases in India. Oral Squamous Cell Carcinoma (SCC) is a serious and developing concern globally, accounting for more than 90% of malignant cancers of the oral cavity. Salivary diagnostics have been demonstrated to have potential in the detection and screening of oral pre-cancer and cancer in a variety of research settings...
2024: Indian Journal of Community Medicine
https://read.qxmd.com/read/38656713/tumor-lysis-syndrome-following-letrozole-for-locally-advanced-breast-cancer-a-case-report
#11
JOURNAL ARTICLE
Masayuki Kikuchi, Rika Miyabe, Hirokazu Matsushima, Hidenori Kita, Junko Kobayashi, Takashi Ando, Koji Atsuta, Tsunehiro Shintani
BACKGROUND: Letrozole, an aromatase inhibitor, is used to treat breast cancer in postmenopausal women. Tumor lysis syndrome (TLS) is a complication that can trigger multiple organ failure caused by the release of intracellular nucleic acids, phosphate, and potassium into the blood due to rapid tumor cell disintegration induced by drug therapy. TLS is uncommon in solid tumors and occurs primarily in patients receiving chemotherapy. Herein, we report a rare occurrence of TLS that developed in a patient with locally advanced breast cancer following treatment with letrozole...
April 24, 2024: Surgical Case Reports
https://read.qxmd.com/read/38656636/limited-prognostic-role-of-routine-serum-markers-ap-cea-ldh-and-nse-in-oligorecurrent-prostate-cancer-patients-undergoing-psma-radioguided-surgery
#12
JOURNAL ARTICLE
Gisa Mehring, Christina Steinbach, Randi Pose, Sophie Knipper, Daniel Koehler, Stefan Werner, Sabine Riethdorf, Gunhild von Amsberg, Francesca Ambrosini, Tobias Maurer
INTRODUCTION: We evaluated the prognostic role of pre-salvage prostate-specific membrane antigen-radioguided surgery (PSMA-RGS) serum levels of alkaline phosphatase (AP), carcinoembryonic antigen (CEA), lactate dehydrogenase (LDH), and neuron-specific enolase (NSE). MATERIALS AND METHODS: Patients who consecutively underwent PSMA-RGS for prostate cancer (PCa) oligorecurrence between January 2019 and January 2022 were selected. Biomarkers were assessed one day before surgery...
April 24, 2024: World Journal of Urology
https://read.qxmd.com/read/38653315/hesperidin-nanoparticles-for-prostate-cancer-therapy-preparation-characterization-and-cytotoxic-activity
#13
JOURNAL ARTICLE
Mohammad Amin Bakhshan, Sanaz Sheikhzadeh, Nowruz Delirezh
Hesperidin, a phytochemical renowned for its therapeutic effects including anticancer, antioxidant, and anti-inflammatory properties, encounters a significant limitation in its application due to its low bioavailability and restricted solubility in water. To surmount these challenges, we employed a spontaneous emulsification method to produce hesperidin nanoparticles. These nanoparticles, averaging 197.2±2.8 nm, exhibited uniform dispersion (Polydispersity index (PDI): 0.13), a zeta potential (ZP) of -28 mV, encapsulation efficiency of 84...
April 23, 2024: Biomedical Materials
https://read.qxmd.com/read/38651543/betaine-ameliorates-doxorubicin-induced-cardiomyopathy-by-inhibiting-oxidative-stress-inflammation-and-fibrosis-through-the-modulation-of-ampk-nrf2-tgf-%C3%AE-expression
#14
JOURNAL ARTICLE
Sumeet Kumar Singh, Poonam Yadav, Dhaneshvaree Patel, Sampat Singh Tanwar, Abhishek Sherawat, Amit Khurana, Jasvinder Singh Bhatti, Umashanker Navik
Doxorubicin (DOX) is a broad-spectrum antibiotic with potent anti-cancer activity. Nevertheless, despite having effective anti-neoplasm activity, its use has been clinically restricted due to its life-threatening side effects, such as cardiotoxicity. It is evident that betaine has anti-oxidant, and anti-inflammatory activity and has several beneficial effects, such as decreasing the amyloid-β generation, reducing obesity, improving steatosis and fibrosis, and activating AMP-activated protein kinase (AMPK)...
April 23, 2024: Environmental Toxicology
https://read.qxmd.com/read/38648891/exploration-of-the-underlying-mechanism-of-astragaloside-iii-in-attenuating-immunosuppression-via-network-pharmacology-and-vitro-vivo-pharmacological-validation
#15
JOURNAL ARTICLE
Yining He, Heba M Amer, Zonghui Xu, Lin Liu, Shujing Wu, Beihui He, Junqiu Liu, Guoyin Kai
ETHNOPHARMACOLOGICAL RELEVANCE: Astragalus mongholicus Bunge (AM, recorded in https://www.worldfloraonline.org, 2023-08-03) is a kind of medicine food homology plant with a long medicinal history in China. Astragaloside III (AS-III) has immunomodulatory effects and is one of the most active components in AM. However, its underlying mechanism of action is still not fully explained. AIM OF THE STUDY: The research was designed to discuss the protective effects of AS-III on immunosuppression and to elucidate its prospective mechanism...
April 20, 2024: Journal of Ethnopharmacology
https://read.qxmd.com/read/38644868/evaluation-of-core-shell-fe-3-o-4-au-nanoparticles-as-radioenhancer-in-a549%C3%A2-cell-lung-cancer-model
#16
JOURNAL ARTICLE
Youssef Slama, Angelique Arcambal, Axelle Septembre-Malaterre, Anne-Laure Morel, Sabrina Pesnel, Philippe Gasque
In radiotherapy, metallic nanoparticles are of high interest in the fight against cancer for their radiosensitizing effects. This study aimed to evaluate the ability of core-shell Fe3 O4 @Au nanoparticles to potentiate the irradiation effects on redox-, pro-inflammatory markers, and cell death of A549 human pulmonary cancer cells. The hybrid Fe3 O4 @Au nanoparticles were synthesized using green chemistry principles by the sonochemistry method. Their characterization by transmission electron microscopy demonstrated an average size of 8 nm and a homogeneous distribution of gold...
April 30, 2024: Heliyon
https://read.qxmd.com/read/38637360/protective-effects-of-arbutin-against-doxorubicin-induced-cardiac-damage
#17
JOURNAL ARTICLE
Oguzhan Birdal, Irmak Ferah Okkay, Ufuk Okkay, Cemil Bayram, Behzad Mokthare, Muhammed Sait Ertugrul, Ahmet Hacimuftuoglu, Emrah Aksakal, Yavuzer Koza, Mehmet Saygi, Huseyin Senocak
BACKGROUND: Doxorubicin is an effective antineoplastic agent but has limited clinical application because of its cumulative toxicities, including cardiotoxicity. Cardiotoxicity causes lipid peroxidation, genetic impairment, oxidative stress, inhibition of autophagy, and disruption of calcium homeostasis. Doxorubicin-induced cardiotoxicity is frequently tried to be mitigated by phytochemicals, which are derived from plants and possess antioxidant, anti-inflammatory, and anti-apoptotic properties...
April 18, 2024: Molecular Biology Reports
https://read.qxmd.com/read/38631393/anticancer-potency-of-egyptian-venom-snakes-on-mcf-7-and-hepg2-carcinoma-cells
#18
JOURNAL ARTICLE
Sherif Abdallah, Khaled Y Abdel-Halim, Abeer Alm-Eldeen
Breast and hepatic cancers are the leading incidences in the globe occurring of the human sufferings from various cancers. Snake venoms have been reported to provide effective therapeutic agents. The current study investigates the anticancer potency of Egyptian venoms snakes on two cells: breast cancer cells (MCF-7) and hepato-cancer cells (HepG2) (In vitro assay). The examined venoms were more potent on MCF-7 than HepG2 cells. Their inhibition % on MCF-7 ranged from 71.47 to 99.02% with medium inhibition concentrations (IC50s): 3...
March 2024: Environmental analysis, health and toxicology
https://read.qxmd.com/read/38626608/aflatoxin-b1-inhibited-the-development-of-primary-myoblasts-of-grass-carp-ctenopharyngodon-idella-by-degrading-extracellular-matrix
#19
JOURNAL ARTICLE
Xiang-Ning He, Wei-Dan Jiang, Pei Wu, Yang Liu, Hong-Mei Ren, Xiao-Wan Jin, Sheng-Yao Kuang, Ling Tang, Shu-Wei Li, Lin Feng, Xiao-Qiu Zhou
According to the International Agency for Research on Cancer (IARC), aflatoxin B1 (AFB1) has been recognized as a major contaminant in food and animal feed and which is a common mycotoxin with high toxicity. Previous research has found that AFB1 inhibited zebrafish muscle development. However, the potential mechanism of AFB1 on fish muscle development is unknown, so it is necessary to conduct further investigation. In the present research, the primary myoblast of grass carp was used as a model, we treated myoblasts with AFB1 for 24 h...
April 15, 2024: Ecotoxicology and Environmental Safety
https://read.qxmd.com/read/38623092/tempol-effect-on-oxidative-and-mitochondrial-markers-in-preclinical-models-for-prostate-cancer
#20
JOURNAL ARTICLE
Isabela Maria Urra Rossetto, Felipe Rabelo Santos, Heloina Mariano da Silva, Elaine Minatel, Mariana Mesquitta, Marcos José Salvador, Fábio Montico, Valéria Helena Alves Cagnon
BACKGROUND: Tempol is a redox-cycling nitroxide considered a potent antioxidant. The present study investigated the tempol effects on oxidative stress and mitochondrial markers on prostate cancer (PCa). METHODS: PC-3 and LnCaP cells were exposed to tempol. Cell viability test, western blot and Amplex Red analyses were performed. In vivo, five experimental groups evaluated tempol effects in the early (CT12 and TPL12 groups) and late stages (CT20, TPL20-I, and TLP20-II) of PCa development...
April 2024: Toxicology Research
keyword
keyword
107582
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.